|
1
|
Adra S, Alabrach Y, Hashem A, Mahmoud A,
Khalouf A, El-Khapery A, Abdelhay A, Mansour M, Aldaher B, Barqawi
H and Abu-Gharbieh E: Trends of primary liver cancer incidence and
mortality in the United States: A population-based study over the
last four decades. PLoS One. 19:e03094652024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khan A and Dhir M: An update on the global
trends in the burden of primary liver cancers. J Surg Oncol.
128:972–979. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S,
Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu
YP, Acevedo-Arozena A, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy (4th edition)1.
Autophagy. 17:1–382. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Minici R, Venturini M, Guzzardi G, Fontana
F, Coppola A, Piacentino F, Torre F, Spinetta M, Maglio P,
Guerriero P, et al: Prognostic role of lymphocyte-to-monocyte ratio
(LMR) in patients with intermediate-stage hepatocellular carcinoma
(HCC) undergoing chemoembolizations (DEM-TACE or cTACE) of the
liver: Exploring the link between tumor microenvironment and
interventional radiology. Diseases. 12:1372024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiao W, Xiong Y, Li K, Jin R and Zhang Y:
Incorporating inflammatory markers and clinical indicators into a
predictive model of single small hepatocellular carcinoma
recurrence after primary locoregional treatments. J Hepatocell
Carcinoma. 11:1113–1125. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salari A, Ghahari M, Bitaraf M, Fard ES,
Haddad M, Momeni SA, Inanloo SH, Ghahari P, Mohamoud MM,
Mohamadzadeh M, et al: Prognostic value of NLR, PLR, SII, and dNLR
in urothelial bladder cancer following radical cystectomy. Clin
Genitourin Cancer. 22:1021442024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang M, Lin SQ, Liu XY, Tang M, Hu CL,
Wang ZW, Zhang Q, Zhang X, Song MM, Ruan GT, et al: Association
between C-reactive protein-albumin-lymphocyte (CALLY) index and
overall survival in patients with colorectal cancer: From the
investigation on nutrition status and clinical outcome of common
cancers study. Front Immunol. 14:11314962023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huai Q, Luo C, Song P, Bie F, Bai G, Li Y,
Liu Y, Chen X, Zhou B, Sun X, et al: Peripheral blood inflammatory
biomarkers dynamics reflect treatment response and predict
prognosis in non-small cell lung cancer patients with neoadjuvant
immunotherapy. Cancer Sci. 114:4484–4498. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Li X, Liu M, Zhou H and Shao J:
Association between monocyte-to-lymphocyte ratio and prostate
cancer in the U.S. population: A population-based study. Front Cell
Dev Biol. 12:13727312024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng X, Feng GY, Tao J, Ao YP, Wu XH, Qi
SG, Shi ZR and Gao LY: Relationships among serological indicators
and in vitro high-throughput drug sensitivity screening results in
patients with hepatocellular carcinoma. Comb Chem High Throughput
Screen. 26:2024.(Online ahead of print). PubMed/NCBI
|
|
11
|
Pinto TAM, Saito HPA, Nourani CL, Ataide
EC, Boin IFSF, Lourenco GJ and Lima CSP: Clinicopathological
aspects and inflammation-immune markers in alcohol and/or hepatitis
C virus-induced hepatocellular carcinoma patients treated with
sorafenib. Gastroenterology Res. 17:23–31. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Young S, Cam I, Gencturk M, Rubin N,
D'souza D, Flanagan S, Golzarian J and Sanghvi T: Inflammatory
scores: Comparison and utility in HCC patients undergoing
transarterial chemoembolization in a North American cohort. J
Hepatocell Carcinoma. 8:1513–1524. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen J, Huang W, Xu X, Fan S, Zhang Q, Li
X, Zeng Z and He J: Prognostic implications of systemic
immune-inflammation index in patients with bone metastases from
hepatocellular carcinoma treated with radiotherapy. Front Oncol.
13:10764282023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
European Association for the Study of the
Liver, . EASL Clinical Practice Guidelines: Management of
hepatocellular carcinoma. J Hepatol. 70:8172019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dharmapuri S, Özbek U, Jethra H, Jun T,
Marron TU, Saeed A, Huang YH, Muzaffar M, Pinter M, Balcar L, et
al: Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte
ratio appear predictive of immune treatment related toxicity in
hepatocellular carcinoma. World J Gastrointest Oncol. 15:1900–1912.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garley M, Nowak K and Jabłońska E:
Neutrophil microRNAs. Biol Rev Camb Philos Soc. 99:864–877. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian W, Wei W, Qin G, Bao X, Tong X, Zhou
M, Xue Y, Zhang Y and Shao Q: Lymphocyte homing and recirculation
with tumor tertiary lymphoid structure formation: Predictions for
successful cancer immunotherapy. Front Immunol. 15:14035782024.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He C, Zhang Y, Cai Z and Lin X: The
prognostic and predictive value of the combination of the
neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio
in patients with hepatocellular carcinoma who receive transarterial
chemoembolization therapy. Cancer Manag Res. 11:1391–1400. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo W, Li Y, Li L, Mu J, Wang B, Niu Z,
Ning Y and Liu L: Predictive value of preoperative inflammatory
indexes for postoperative early recurrence of hepatitis B-related
hepatocellular carcinoma. Front Oncol. 13:11421682023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Y, Zhou J, Liu Z, Wu T, Li S, Zhang
Y, Yin X, Yang G and Zhang G: Tumor cell-induced platelet
aggregation accelerates hematogenous metastasis of malignant
melanoma by triggering macrophage recruitment. J Exp Clin Cancer
Res. 42:2772023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Strasenburg W, Jóźwicki J, Durślewicz J,
Kuffel B, Kulczyk MP, Kowalewski A, Grzanka D, Drewa T and
Adamowicz J: Tumor cell-induced platelet aggregation as an emerging
therapeutic target for cancer therapy. Front Oncol. 12:9097672022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Shi HY and Zhou M: Correlation
between preoperative systemic immune inflammation index,
nutritional risk index, and prognosis of radical resection of liver
cancer. World J Gastrointest Surg. 15:2445–2455. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xin Y, Yang Y, Liu N, Chen Y, Wang Y,
Zhang X, Li X and Zhou X: Prognostic significance of systemic
immune-inflammation index-based nomogram for early stage
hepatocellular carcinoma after radiofrequency ablation. J
Gastrointest Oncol. 12:735–750. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Öcal O, Kimm MA, Hoang TPT, Pech M, Öcal
E, Khaled NB, Sangro B and Ricke J: Predictive value of
platelet-to-lymphocyte and neutrophil-to-lymphocyte ratio in HCC
treated with sorafenib and radioembolization. JHEP Rep.
6:1009952023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang D, Bai N, Hu X, OuYang XW, Yao L, Tao
Y and Wang Z: Preoperative inflammatory markers of NLR and PLR as
indicators of poor prognosis in resectable HCC. PeerJ. 7:e71322019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu M, Yang S, Feng X, Li C, Liu X, Zhang
Z, Xiao Y, Liu C and Dong J: Combining preoperative and
postoperative inflammatory indicators can better predict the
recurrence of hepatocellular carcinoma after partial hepatectomy. J
Inflamm Res. 14:3231–3245. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giraud J, Chalopin D, Ramel E, Boyer T,
Zouine A, Derieppe MA, Larmonier N, Adotevi O, Bail BL, Blanc JF,
et al: THBS1+ myeloid cells expand in SLD hepatocellular
carcinoma and contribute to immunosuppression and unfavorable
prognosis through TREM1. Cell Rep. 43:1137732024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pei J, Gao Y and Wu A: An
inflammation-related subtype classification for analyzing tumor
microenvironment and clinical prognosis in colorectal cancer. Front
Immunol. 15:13697262024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu JE, Yeo IJ, Han SB, Yun J, Kim B, Yong
YJ, Lim YS, Kim TH, Son DJ and Hong J: Significance of
chitinase-3-like protein 1 in the pathogenesis of inflammatory
diseases and cancer. Exp Mol Med. 56:1–18. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang D, Hu X, Xiao L, Long G, Yao L, Wang
Z and Zhou L: Prognostic nutritional index and systemic
immune-inflammation index predict the prognosis of patients with
HCC. J Gastrointest Surg. 25:421–427. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karageorgos SA, Stratakou S, Koulentaki M,
Voumvouraki A, Mantaka A, Samonakis D, Notas G and Kouroumalis EA:
Long-term change in incidence and risk factors of cirrhosis and
hepatocellular carcinoma in crete, Greece: A 25-year study. Ann
Gastroenterol. 30:357–363. 2017.PubMed/NCBI
|
|
32
|
Liu P, Xie SH, Hu S, Cheng X, Gao T, Zhang
C and Song Z: Age-specific sex difference in the incidence of
hepatocellular carcinoma in the United States. Oncotarget.
8:68131–68137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Konyn P, Ahmed A and Kim D: Current
epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol
Hepatol. 15:1295–1307. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lampimukhi M, Qassim T, Venu R, Pakhala N,
Mylavarapu S, Perera T, Sathar BS and Nair A: A review of incidence
and related risk factors in the development of hepatocellular
carcinoma. Cureus. 15:e494292023.PubMed/NCBI
|
|
35
|
Nevola R, Tortorella G, Rosato V, Rinaldi
L, Imbriani S, Perillo P, Mastrocinque D, La Montagna M, Russo A,
Di Lorenzo G, et al: Gender differences in the pathogenesis and
risk factors of hepatocellular carcinoma. Biology (Basel).
12:9842023.PubMed/NCBI
|
